“…Many spectrophotometric procedures have been proposed for the estimation of MD in pharmaceutical preparations including difference UV-spectrophotometric assay in the presence of germanium dioxide at 292 nm [22], Flowinjection spectrophotometry [23][24][25][26], fluorimetry [27,28], kinetic spectrophotometry [29][30][31] and extractive spectrophotometry [32,33]. Moreover, the colorimetric method was the most widespread for estimation of MD in dosage form using I2 solution with acetate buffer of pH 4.7 [4], 2-aminothiazole in alkaline medium [25], thiosemicarbazide in presence of ferric nitrate [26], NH4VO3 in the presence H3PO4 [34], (NH4)6Mo7O24.4H2O solution in H2SO4 [35], Fe(III)-ophenanthroline [36], barbituric acid [37], isoniazid in presence of Nbromosuccinamide [38], diazotised sulphanilamide in the presence of molybdate [39], periodate in H2SO4 and determination of unreacted periodate by adding methylene blue and KI [40], iron (III) in the presence of 1,10phenanthroline and 2,2'-bipyridyl [41], p-nitroaniline in the presence of molybdate ions in acidic medium [42], Ce(IV) nitrate solution in H2SO4 [43], bromothymol blue in alkaline medium [44], sodium nitrite in an acid medium and further reacting the resultant nitroso derivative with sodium hydroxide [45], 2,2-diphenyil-picrylhydrazyl [46], 2,6dichloroquinone-4-chlorimide in acetate buffer and in water and ethanol solvents [47] and p-phenylenediamine in phosphate buffer at pH 7.4 [48]. 3-methylbenzothiazolin-2one hydrazone hydrochloride (MBTH) was used with (NH4)2SO4.Ce(SO4)2 in acetone or with K2Cr2O7 in methanol medium to determine MD.…”